R-Lipoic Acid vs Racemic Alpha-Lipoic Acid: What Differs
What is documented about R-lipoic acid versus the usual racemic alpha-lipoic acid mix: small absorption and tolerability studies, no proven winner, plus safety points.
Content last updated . This page has not been medically reviewed.
Quick answer
Alpha-lipoic acid (ALA) comes as two mirror-image forms, R and S. Many supplements and most trials use a 1:1 mix of the two (called racemic, or R,S). Others contain only the R form. The documented differences are small: one crossover trial found similar R-form blood levels and fewer stomach complaints on R-lipoic acid alone, and a small wound-healing trial favored it. No trial we found compared the two forms on diabetes, nerve or other major health outcomes, so there is no proven winner. This page is information only.
What the terms mean
ALA contains a chiral carbon, so it exists as two enantiomers, R-ALA and S-ALA. [1] The R form is the one found naturally: a pharmacology paper describes R(+)-alpha-lipoic acid as a naturally occurring compound that acts as a cofactor for certain enzyme complexes. [2] A "racemic" supplement is a 1:1 mixture of R and S. [3]A reminder about the word "antioxidant": ALA is often called one, but test-tube antioxidant activity is not a health outcome. The studies below measure absorption, side effects and, in one case, wound healing.
Evidence labels used here: biomarker only (blood level), promising but limited, insufficient evidence, and "Proper evidence not found" where we searched and found nothing usable.
Documented differences, side by side
| Question | What the sources found | Strength |
|---|---|---|
| Is R absorbed better than S? | Authors of a cell study cite earlier work showing oral bioavailability of R is better than S, and found the difference did not come from gut-wall permeability, which was similar for both. [1] | Cell study citing earlier work; not a supplement trial |
| Does R alone give the same R level as the racemic mix? | In 20 people with progressive multiple sclerosis (MS), 600 mg of R-ALA alone and 1200 mg of the 1:1 mix (which contains the same R amount) gave bioequivalent R-ALA blood levels, over 7 to 10 days per form. [3] | Biomarker only; small; one condition |
| Is R alone easier on the stomach? | The same trial counted fewer stomach side effects on R-ALA than on the racemic mix (31 vs 60 reports, P = .025). The overall symptom score was 1.7 points lower on R-ALA but did not reach statistical significance (P = .069). Two people dropped out on the mix and one on R-ALA. [3] | Promising but limited; 20 people, crossover |
| Does the form change a health outcome? | One small trial added ALA or R-ALA to hyperbaric oxygen therapy for chronic leg wounds: ulcers improved more with R-ALA, and it reduced one inflammation marker (IL-6) that the mix did not. [4] The abstract does not give group sizes. | Insufficient evidence; one small trial, specific treatment setting |
| Diabetes, nerve pain, blood sugar | Proper evidence not found for R versus racemic. | n/a |
The 2020 trial tested one amount of each form in people with MS, so it does not tell us what happens in healthy adults or in people with diabetes. Amounts here are study amounts, not advice.
Formulation matters as much as the form
R-ALA is described as unstable against heat or acid, and a stabilized R-ALA complex gave about 2.5 times the blood exposure of plain R-ALA in six healthy volunteers. [5] Several authors list a company as an affiliation, and this is a comparison of formulations, not of R versus racemic. For the usual mix, a study of healthy volunteers described limited absolute bioavailability of about 30% because the liver removes much of it. [2] So label claims about absorption describe a specific product; see quality testing and reading supplement labels.What the larger ALA trials do and do not tell us
Reviews of diabetic nerve damage (neuropathy) are about ALA in general. A 2023 meta-analysis of ten randomized trials (1,242 people) of oral ALA found better symptom scores and global satisfaction than placebo, but no favorable result for several other measures such as nerve conduction. [6] A 2012 meta-analysis of 15 trials using 300 to 600 mg by vein found improved nerve conduction speeds, but said the evidence may not be strong because most studies were of poor quality. [7] These abstracts do not separate R from racemic, so their results should not be assigned to R-ALA. The NCCIH (US) says a 2022 review found inconsistent results for diabetic neuropathy and that most diabetes-supplement studies are limited in size and differ in formulations. [8] See ALA for diabetic neuropathy and blood sugar and the main alpha-lipoic acid page.Frequently asked questions
Is R-lipoic acid stronger than regular alpha-lipoic acid?
Not shown. A trial in people with MS found similar R-ALA blood levels from R-ALA alone and from the racemic mix that contained the same R amount. [3]
Does R-lipoic acid cause fewer stomach problems?
In one 20-person crossover trial, there were fewer stomach side effects reported on R-ALA (31 vs 60), though the overall symptom score difference was not statistically significant. [3]
Is the S form harmful?
Our sources do not say so. They compare absorption and tolerability only, and we found no safety trial isolating the S form.
Is one form better for diabetic nerve pain or blood sugar?
Proper evidence not found. The neuropathy meta-analyses we read do not separate R from racemic. [6][7]
Can alpha-lipoic acid affect blood sugar?
Case reports and reviews link it to insulin autoimmune syndrome with repeated low blood sugar, so people with diabetes should ask a clinician first. [9]
More details: evidence, limits and cautions
The details behind this page: cautions, limits of the evidence and where sources disagree. Open any note to read it.
Safety, interactions and who should ask first
- Common side effects. NCCIH lists headache, heartburn, nausea and vomiting. [8]
- Low blood sugar. A 2026 review reports an increasing number of cases of insulin autoimmune syndrome attributed to ALA, which causes repeated episodes of low blood sugar that may alternate with high readings. [9] It is rare, but anyone with diabetes, or taking diabetes medicine, should speak to a clinician or pharmacist before using it. Repeated shakiness, sweating or confusion needs prompt medical attention, and call 911 for collapse or severe confusion. This applies to both forms; the reports we read do not distinguish them.
- Medicines. See medication interactions and ALA side effects and cautions.
- Kidney disease. NCCIH says that if you have or are at risk for kidney disease, a health care provider should closely monitor your supplement use. [8] Liver safety of ALA is not described in the sources we read.
- Pregnancy and breastfeeding. A 2014 narrative review proposed ALA for pregnancy-related nerve pain and called the data promising. [10] That is a review of the authors' reading, not a safety guarantee. Ask a clinician: pregnancy and breastfeeding. Safety in children is not described in the sources we read.
- Before surgery. Tell the care team: supplements before surgery.
- Official intake levels. None of the sources we read gives an official recommended intake or upper limit for ALA, so none is stated.
A clinician or pharmacist can help talk through supplements with you.
References
- Uchida R, Okamoto H, Ikuta N, et al. Investigation of enantioselective membrane permeability of alpha-lipoic acid in Caco-2 and MDCKII cells. Int J Mol Sci 2016 (PubMed abstract). Read 2026-10-23.
- Teichert J, Hermann R, Ruus P, Preiss R. Plasma kinetics, metabolism, and urinary excretion of alpha-lipoic acid following oral administration in healthy volunteers. J Clin Pharmacol 2003 (PubMed abstract). Read 2026-10-23.
- Cameron M, Taylor C, Lapidus J, et al. Gastrointestinal tolerability and absorption of R- versus R,S-lipoic acid in progressive multiple sclerosis: a randomized crossover trial. J Clin Pharmacol 2020 (PubMed abstract). Read 2026-10-23.
- Nasole E, Nicoletti C, Yang ZJ, et al. Effects of alpha lipoic acid and its R+ enantiomer supplemented to hyperbaric oxygen therapy on interleukin-6, TNF-alpha and EGF production in chronic leg wound healing. J Enzyme Inhib Med Chem 2014 (PubMed abstract). Read 2026-10-23.
- Ikuta N, Okamoto H, Furune T, et al. Bioavailability of an R-alpha-lipoic acid/gamma-cyclodextrin complex in healthy volunteers. Int J Mol Sci 2016 (PubMed abstract). Read 2026-10-23.
- Hsieh RY, Huang IC, Chen C, Sung JY. Effects of oral alpha-lipoic acid treatment on diabetic polyneuropathy: a meta-analysis and systematic review. Nutrients 2023 (PubMed abstract). Read 2026-10-23.
- Han T, Bai J, Liu W, Hu Y. A systematic review and meta-analysis of alpha-lipoic acid in the treatment of diabetic peripheral neuropathy. Eur J Endocrinol 2012 (PubMed abstract). Read 2026-10-23.
- Diabetes and Dietary Supplements: What You Need To Know. National Center for Complementary and Integrative Health (US), page last updated November 2023. Read 2026-10-23.
- Vallianou NG, Kounatidis DC, Dalamaga M, et al. Alpha-lipoic acid as a trigger of insulin autoimmune syndrome. Metabol Open 2026 (PubMed abstract). Read 2026-10-23.
- Costantino M, Guaraldi C, Costantino D, De Grazia S, Unfer V. Peripheral neuropathy in obstetrics: efficacy and safety of alpha-lipoic acid supplementation. Eur Rev Med Pharmacol Sci 2014 (PubMed abstract). Read 2026-10-23.
Education, not medical advice. This page is for general information. It does not diagnose or treat any condition and is not a substitute for care from a qualified health professional. Natural does not automatically mean safe. Ask a clinician or pharmacist before changing your care, especially if you take medication, are pregnant or breastfeeding, or have a health condition.